insights_auto
Why is CSBR down 3,30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
USDÂ 4,44
arrow_downward
-3,30%(-0,15) 1D
18 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USDÂ 4,55
High
USDÂ 4,60
Low
USDÂ 4,41
Mkt. cap
61,82Â m
Avg. vol.
7,41Â k
Volume
11,73Â k
52-wk high
USDÂ 8,31
52-wk low
USDÂ 4,41
EPS
-USDÂ 0,08
Beta
0,47
Shares outstanding
13,92Â m
No. of employees
217
Open
USDÂ 4,55
High
USDÂ 4,60
Low
USDÂ 4,41
Mkt. cap
61,82Â m
Avg. vol.
7,41Â k
Volume
11,73Â k
52-wk high
USDÂ 8,31
52-wk low
USDÂ 4,41
EPS
-USDÂ 0,08
Beta
0,47
Shares outstanding
13,92Â m
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
1 uur gelede
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Barron's
·
3 uur gelede
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Hedgeye
·
9 uur gelede
Why Negative Gamma Has Taken the Brakes Off the S&P 500
24/7 Wall St.
·
3 uur gelede
Forget Market Crashes: These Dow Jones Giants Have Recession-Proof Dividends
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com